SLC34A2 and ovarian cancer: In our study, the IHC expression of SLC34A2 increased in PTC samples as compared to normal thyroid tissue, which is similar to the expression pattern observed in ovarian cancer [16], breast cancer [17, 18], and osteosarcoma [19].